STOCK TITAN

SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
SOPHiA GENETICS, a data-driven medicine leader, will announce its Q1 2024 financial results on May 7, 2024. A conference call discussing the results and business outlook will follow, webcast live on their Investor Relations website.
SOPHiA GENETICS, leader nella medicina basata sui dati, annuncerà i risultati finanziari del primo trimestre 2024 il 7 maggio 2024. Seguirà una teleconferenza per discutere i risultati e le prospettive aziendali, che sarà trasmessa in diretta sul sito web delle Relazioni con gli Investitori.
SOPHiA GENETICS, líder en medicina basada en datos, anunciará sus resultados financieros del primer trimestre de 2024 el 7 de mayo de 2024. Posteriormente, se realizará una conferencia telefónica para discutir los resultados y las perspectivas empresariales, que se retransmitirá en directo en su sitio web de Relaciones con Inversores.
데이터 기반 의학 분야의 선두주자인 SOPHiA GENETICS가 2024년 1분기 재무 결과를 2024년 5월 7일에 발표할 예정입니다. 이어서 결과 및 사업 전망에 대해 논의하는 컨퍼런스 콜이 있을 예정이며, 이는 투자자 관계 웹사이트에서 실시간 웹캐스트로 진행됩니다.
SOPHiA GENETICS, leader de la médecine basée sur les données, annoncera ses résultats financiers du premier trimestre 2024 le 7 mai 2024. Une conférence téléphonique discutant des résultats et des perspectives d'affaires suivra, diffusée en direct sur leur site web des Relations Investisseurs.
SOPHiA GENETICS, ein Vorreiter in der datengesteuerten Medizin, wird am 7. Mai 2024 die Finanzergebnisse für das erste Quartal 2024 bekanntgeben. Anschließend findet ein Telefonkonferenzgespräch statt, in dem die Ergebnisse und die Geschäftsaussichten besprochen werden, welches live auf der Website für Investorenbeziehungen übertragen wird.
Positive
  • None.
Negative
  • None.

BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal year 2024 before U.S. markets open on Tuesday, May 7, 2024. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET.

The call will be webcast live on the SOPHiA GENETICS Investor Relations website. Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of SOPHiA DDM™, a platform that analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.


FAQ

When will SOPHiA GENETICS announce its financial results for Q1 2024?

SOPHiA GENETICS will announce its financial results for the first quarter of fiscal year 2024 on May 7, 2024.

What time will the conference call to discuss the financial results and business outlook start?

The conference call will start at 8:00 a.m. EDT / 2:00 p.m. CET on May 7, 2024.

Where can I watch the live webcast of the conference call?

The live webcast of the conference call can be accessed on the SOPHiA GENETICS Investor Relations website.

Will a replay of the conference call be available?

Yes, a replay of the conference call will be available on the SOPHiA GENETICS Investor Relations website after its completion.

SOPHiA GENETICS SA Ordinary Shares

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Stock Data

241.89M
65.38M
5.84%
49.85%
0.02%
Health Information Services
Healthcare
Link
United States of America
Rolle